Cargando…
Comparison of remission criteria in a tumour necrosis factor inhibitor treated rheumatoid arthritis longitudinal cohort: patient global health is a confounder
INTRODUCTION: Our objectives were to assess the frequency and sustainability of American College of Rheumatology (ACR)/European League against Rheumatism (EULAR) and Disease Activity Score (DAS)28(4v)–C-reactive protein (CRP) remission 12 months after the initiation of tumour necrosis factor inhibit...
Autores principales: | Balogh, Emese, Madruga Dias, Joao, Orr, Carl, Mullan, Ronan, Harty, Len, FitzGerald, Oliver, Gallagher, Phil, Molloy, Miriam, O’Flynn, Eileen, Kelly, Alexia, Minnock, Patricia, O’Neill, Madeline, Moore, Louise, Murray, Mairead, Fearon, Ursula, Veale, Douglas J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978469/ https://www.ncbi.nlm.nih.gov/pubmed/24365061 http://dx.doi.org/10.1186/ar4421 |
Ejemplares similares
-
Remission in psoriatic arthritis: is it possible and how can it be predicted?
por: Saber, Tajvur P, et al.
Publicado: (2010) -
Long-term remission and biologic persistence rates: 12-year real-world data
por: Murray, Kieran, et al.
Publicado: (2021) -
Functionally Mature CD1c(+) Dendritic Cells Preferentially Accumulate in the Inflammatory Arthritis Synovium
por: Canavan, Mary, et al.
Publicado: (2021) -
CD209/CD14(+) Dendritic Cells Characterization in Rheumatoid and Psoriatic Arthritis Patients: Activation, Synovial Infiltration, and Therapeutic Targeting
por: Marzaioli, Viviana, et al.
Publicado: (2022) -
Oncostatin M in rheumatoid arthritis: a key cytokine acts synergistically with other proinflammatory cytokines to promote human cartilage loss
por: Fearon, U, et al.
Publicado: (2005)